Q4 2017 Holdings
Filed 2018-02-13 | 18 holdings | $98.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $44.6M | 1,113,014 | 45.5% |
| Argenx(ARGX) | COM | 04016X101 | $41.0M | 649,665 | 41.8% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $12.2M | 2,482,119 | 12.4% |
| AveXis Inc | COM | 05366U100 | $114.6K | 1,035,657 | 0.1% |
| Biohaven Pharmaceuticals(BHVN) | COM | G11196105 | $46.4K | 1,718,605 | 0.0% |
| Zogenix | COM | 98978L204 | $34.2K | 854,057 | 0.0% |
| AnaptysBio(ANAB) | COM | 032724106 | $28.5K | 282,550 | 0.0% |
| DBV Technologies | COM | F2927N109 | $20.7K | 673,617 | 0.0% |
| Obseva SA | COM | H5861P103 | $19.4K | 1,988,843 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $18.7K | 1,259,500 | 0.0% |
| Bellerophon Therapeutics(BLPHEUR) | COM | 078771102 | $9.7K | 4,149,378 | 0.0% |
| Edge Therapeutics Inc | COM | 279870109 | $9.1K | 975,103 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $5.7K | 485,615 | 0.0% |
| Ra Pharmaceuticals | COM | 74933V108 | $4.6K | 544,612 | 0.0% |
| Catalyst Biosciences | COM | 14888D109 | $3.2K | 235,676 | 0.0% |
| Akari Therapeutics Plc | COM | 00972G108 | $1.8K | 426,297 | 0.0% |
| Arca biopharma Inc | COM | 00211Y100 | $1.5K | 1,078,932 | 0.0% |
| Lipocine Inc | COM | 53630X104 | $1.3K | 386,928 | 0.0% |